External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Infectious Disease EASL 2025
Roche and Genentech at

EASL 2025

May 07 - May 10
Amsterdam, Netherlands
easl.eu
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
06:00 AM
Duration 60mins Amsterdam, Netherlands
Safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7565020, a novel monoclonal antibody that targets the hepatitis B surface antigen: results from a phase 1 single ascending dose study in healthy volunteers and participants with chronic hepatitis B
Edward Gane
Infectious Disease | Hepatitis B virus infection

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Amsterdam, Netherlands
HBV genotype association with response to xalnesiran in nucleos(t)ide analogue treated participants with chronic hepatitis B infection in the Piranga phase 2 platform study
Rémi Kazma
Infectious Disease | Hepatitis B virus infection

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:00 AM
Duration 60mins Amsterdam, Netherlands
Performance evaluation of the Elecsys Anti-HBc II quant assay
Christian Voitenleitner
Infectious Disease | Hepatitis B virus infection

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Amsterdam, Netherlands
Clinical evaluation of multimarker algorithmic scores for detection of early stage hepatocellular carcinoma in high-risk liver patients
Hidenori Toyoda, Aliya Sarmanova, Konstantin Kroeniger, Takashi Kumada, Ashish Sharma
Oncology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Amsterdam, Netherlands
HBV RNA ultra-deep sequencing as a tool for HBV genotyping and resistance monitoring in virologically-suppressed individuals with chronic hepatitis B infection
Rémi Kazma
Infectious Disease | Hepatitis B virus infection

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.